Stanford Medicine
R

From NAFLD to MASLD: A Paradigm Shift

By Stanford Medicine FEATURING Renumathy Dhanasekaran
By Stanford Medicine FEATURING Renumathy Dhanasekaran
114 views
June 1, 2024
0 Comments
Login to view comments. Click here to Login

Featured Video

18:06
Lilly Obesity

Getting Patients Started with an Obesity Treatment Option for Adults

Feat. E. Lazarus

Featured Video

18:06
Lilly Obesity

Getting Patients Started with an Obesity Treatment Option for Adults

Feat. E. Lazarus

Related Content

AUTOPLAY
47:11
Houston Methodist Hospital

The Protein Myth: Our Obsession With Protein and How It Is Killing US

Feat. G. Davis
49:21
Physicians Committee for Responsible Medicine

Health of Vegetarians and Vegans: Findings From EPIC-Oxford and Othe…

Feat. T. J. Key
34:49
Scripps Health

Medications for Weight Loss: The New Satiety Hormones

Feat. K. Fujioka
15:06
Robert Busch

GLP-1/GIP Update: Stay Tuned... The Best is Yet to Come!!

37:21
University of Colorado Department of Medicine

Evidence that Obesity and Diabetes are Driven by a Diet-Induced Biol…

Feat. R. Johnson
18:46
Houston Methodist Hospital

MAFLD: What Is It?

Feat. D. Victor
19:24
National Lipid Association

Do Triglycerides Cause Heart Disease?

Feat. I. Goldberg
11:36
Columbia University Institute of Human Nutrition

Rainbow Lentil Soup: Columbia / IHN Breast Cancer Awareness Culinary…

Feat. O. Weinstein
26:49
Diana Isaacs

Tirzepatide Updates

26:32
Practical Ways to Achieve Targets in Diabetes Care

Metabolic Surgery vs. Pharmacotherapy for Treatment of Obesity

Feat. S. Nissen
28:05
Michael Makover

The Deadly Paradox: Current Practice, Driven by Guidelines, Is Not A…

44:41
Norman Lepor

Obesity: New Understanding and Treatments

19:26
Krista Varady

ADA 2022 Flipping the Metabolic Switch: Intermittent Fasting as a We…

44:43
Jason Fung

Type 2 Diabetes Aetiology and Reversibility

33:23
Keck School of Medicine of USC

Effects of Low Calorie and Alternative Sweeteners Across the Lifespa…

Feat. M. Goran
06:31
Susan Brian

Discussing Retatrutide: A GIP, GLP-1, and Glucagon Receptor Agonist

05:08
Susan Brian

The Differences Between the Products of GLP1's and GLP/GIPs

22:22
Practical Ways to Achieve Targets in Diabetes Care

Omega-3 Fatty Acids and Cardiovascular Outcomes: Anatomy of a Fish T…

Feat. S. Nissen
21:06
NYU Langone

Pharmacotherapy for Weight Management: Present and Future

Feat. H. Lofton
11:19
PKD Foundation

BMI, Weight Loss, & ADPKD

Feat. K. Hopp